PFE closed at $30.52 on Friday, up 1.9% on the day and 6.3% over the past month, with short interest falling 12% over the week to just 2.3% of the free float and borrow conditions effectively unlimited. The insider story is the standout heading into Monday's print. CEO Albert Bourla spent $1 million buying shares on the open market in August at $26.34, a discretionary purchase with…
PFE cost to borrow surges 158% over one week to 0.375%, as short availability remains elevated at 9,999% of estimated interest.
Key data as of 4 Nov 2026
Pfizer heads into its July 28 earnings report with the Street in a quiet retreat — analysts cutting targets but holding ratings, while positioning data shows no particular stress in either direction. The most telling…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PFE — free to start on ORTEX.
Sign up for free →Open PFE on ORTEX